Skip to main content
Journal cover image

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.

Publication ,  Journal Article
Schnell, O; Battelino, T; Bergenstal, R; Birkenfeld, AL; Ceriello, A; Cheng, A; Davies, M; Edelman, S; Forst, T; Giorgino, F; Green, J; Ji, L ...
Published in: Cardiovasc Diabetol
March 16, 2023

The 8th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Kidney, and Glycemic Outcomes was held virtually on November 10-12, 2022. Following the tradition of previous summits, this reference congress served as a platform for in-depth discussion and exchange on recently completed outcomes trials as well as key trials important to the cardiovascular (CV) field. This year's focus was on the results of the DELIVER, EMPA-KIDNEY and SURMOUNT-1 trials and their implications for the treatment of heart failure (HF) and chronic kidney disease (CKD) with sodium-glucose cotransporter-2 (SGLT2) inhibitors and obesity with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. A broad audience of primary care physicians, diabetologists, endocrinologists, cardiologists, and nephrologists participated online in discussions on new consensus recommendations and guideline updates on type 2 diabetes (T2D) and CKD management, overcoming clinical inertia, glycemic markers, continuous glucose monitoring (CGM), novel insulin preparations, combination therapy, and reclassification of T2D. The impact of cardiovascular outcomes on the design of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) trials, as well as the impact of real-world evidence (RWE) studies on the confirmation of CVOT outcomes and clinical trial design, were also intensively discussed. The 9th Cardiovascular Outcome Trial Summit will be held virtually on November 23-24, 2023 ( http://www.cvot.org ).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cardiovasc Diabetol

DOI

EISSN

1475-2840

Publication Date

March 16, 2023

Volume

22

Issue

1

Start / End Page

59

Location

England

Related Subject Headings

  • Renal Insufficiency, Chronic
  • Kidney
  • Hypoglycemic Agents
  • Humans
  • Glucagon-Like Peptide-1 Receptor
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Blood Glucose Self-Monitoring
  • Blood Glucose
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schnell, O., Battelino, T., Bergenstal, R., Birkenfeld, A. L., Ceriello, A., Cheng, A., … Standl, E. (2023). CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. Cardiovasc Diabetol, 22(1), 59. https://doi.org/10.1186/s12933-023-01788-6
Schnell, Oliver, Tadej Battelino, Richard Bergenstal, Andreas L. Birkenfeld, Antonio Ceriello, Alice Cheng, Melanie Davies, et al. “CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.Cardiovasc Diabetol 22, no. 1 (March 16, 2023): 59. https://doi.org/10.1186/s12933-023-01788-6.
Schnell O, Battelino T, Bergenstal R, Birkenfeld AL, Ceriello A, Cheng A, et al. CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. Cardiovasc Diabetol. 2023 Mar 16;22(1):59.
Schnell, Oliver, et al. “CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.Cardiovasc Diabetol, vol. 22, no. 1, Mar. 2023, p. 59. Pubmed, doi:10.1186/s12933-023-01788-6.
Schnell O, Battelino T, Bergenstal R, Birkenfeld AL, Ceriello A, Cheng A, Davies M, Edelman S, Forst T, Giorgino F, Green J, Groop P-H, Hadjadj S, J L Heerspink H, Hompesch M, Izthak B, Ji L, Kanumilli N, Mankovsky B, Mathieu C, Miszon M, Mustafa R, Nauck M, Pecoits-Filho R, Pettus J, Ranta K, Rodbard HW, Rossing P, Ryden L, Schumm-Draeger P-M, Solomon SD, Škrha J, Topsever P, Vilsbøll T, Wilding J, Standl E. CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes. Cardiovasc Diabetol. 2023 Mar 16;22(1):59.
Journal cover image

Published In

Cardiovasc Diabetol

DOI

EISSN

1475-2840

Publication Date

March 16, 2023

Volume

22

Issue

1

Start / End Page

59

Location

England

Related Subject Headings

  • Renal Insufficiency, Chronic
  • Kidney
  • Hypoglycemic Agents
  • Humans
  • Glucagon-Like Peptide-1 Receptor
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Blood Glucose Self-Monitoring
  • Blood Glucose